Literature DB >> 16772139

Tissue distribution of cefquinome after intramammary and "systemic" administration in the isolated perfused bovine udder.

A M Ehinger1, H Schmidt, M Kietzmann.   

Abstract

Mammary glands taken at slaughter from healthy lactating cows were perfused in vitro with warmed and gassed Tyrode solution. Cefquinome (88.8mg cefquinome sulphate per 8mL) was administered by the intramammary route to all quarters and/or "systemically" via the perfusion fluid at concentrations similar to those measured in plasma following intramuscular administration of 1mg cefquinome per kg body weight. Samples of the perfusate were taken over a 6-h period and from the regional lymph nodes after 6h. Using a scalpel, sections of glandular tissue - at different distances from and vertical to the teat right up to the udder base - were gathered from four quarters each per route of administration at 2, 4 and 6h. The cefquinome content of the tissue samples was analysed by high performance liquid chromatography with diode array detection and of the perfusate samples by bioassay. After intramammary administration, the concentration of cefquinome in the glandular tissue decreased exponentially with increasing distance from the teat. The addition of cefquinome to the perfusion fluid produced a mean concentration of 0.2-0.5microg/g at all glandular tissue sites. Combined intramammary and systemic treatment ensured that concentrations exceeded the MIC(90) values of the most common mastitis pathogens in all areas of the udder by 2h post-administration. There was considerable variability in the tissue concentrations of cefquinome, particularly after intramammary administration. These results suggest that for the treatment of acute mastitis a combination of both intramammary and systemic administration is likely to be advantageous in order to rapidly produce maximum cefquinome concentrations in all regions of the udder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16772139     DOI: 10.1016/j.tvjl.2005.02.029

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  8 in total

1.  Development and validation of a high-performance liquid chromatography method for determination of cefquinome concentrations in sheep plasma and its application to pharmacokinetic studies.

Authors:  Kamil Uney; Feray Altan; Muammer Elmas
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

2.  Pharmacokinetics following intravenous administration and pharmacodynamics of cefquinome in buffalo calves.

Authors:  Venkatathalam Dinakaran; Vinod Kumar Dumka; Bibhuti Ranjan; Ramalingam Balaje; Pritam Kaur Sidhu
Journal:  Trop Anim Health Prod       Date:  2013-03-03       Impact factor: 1.559

3.  Tissue distribution of cloxacillin after intramammary administration in the isolated perfused bovine udder.

Authors:  Manfred Kietzmann; Frank Niedorf; Jacques Gossellin
Journal:  BMC Vet Res       Date:  2010-10-06       Impact factor: 2.741

4.  Systemic and mammary gland disposition of enrofloxacin in healthy sheep following intramammary administration.

Authors:  Cristina López; Juan José García; Matilde Sierra; María José Diez; Claudia Pérez; Ana Maria Sahagún; Nélida Fernández
Journal:  BMC Vet Res       Date:  2015-04-09       Impact factor: 2.741

5.  Integration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle.

Authors:  Ijaz Ahmad; Haihong Hao; Lingli Huang; Pascal Sanders; Xu Wang; Dongmei Chen; Yanfei Tao; Shuyu Xie; Kuang Xiuhua; Juan Li; Wan Dan; Zonghui Yuan
Journal:  Front Microbiol       Date:  2015-06-17       Impact factor: 5.640

6.  Efficacy of cefquinome and a combination of cloxacillin and ampicillin for treatment of dairy cows with Streptococcus agalactiae subclinical mastitis.

Authors:  Rodolfo Santos Rossi; Ariadne Ferreira Amarante; Simony Trevisan Guerra; Giulia Soares Latosinski; Bruna Fernanda Rossi; Vera Lucia Mores Rall; Jose Carlos de Figueiredo Pantoja
Journal:  PLoS One       Date:  2019-04-25       Impact factor: 3.240

7.  Ex Vivo Pharmacokinetics and Pharmacodynamics Modeling and Optimal Regimens Evaluation of Cefquinome Against Bovine Mastitis Caused by Staphylococcus aureus.

Authors:  Li-Jie Jiang; Xia Xiao; Ke-Xu Yan; Tian Deng; Zhi-Qiang Wang
Journal:  Front Vet Sci       Date:  2022-03-08

8.  In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary Infusion.

Authors:  Yang Yu; Yu-Feng Zhou; Mei-Ren Chen; Xiao Li; Gui-Lin Qiao; Jian Sun; Xiao-Ping Liao; Ya-Hong Liu
Journal:  PLoS One       Date:  2016-05-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.